JLKInc Past Earnings Performance
Past criteria checks 0/6
JLKInc has been growing earnings at an average annual rate of 4.6%, while the Healthcare Services industry saw earnings growing at 15.4% annually. Revenues have been growing at an average rate of 15% per year.
Key information
4.6%
Earnings growth rate
10.8%
EPS growth rate
| Healthcare Services Industry Growth | 16.7% |
| Revenue growth rate | 15.0% |
| Return on equity | -186.5% |
| Net Margin | -696.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How JLKInc makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,618 | -11,266 | 9,178 | 1,796 |
| 31 Mar 24 | 1,627 | -10,287 | 8,694 | 1,351 |
| 31 Dec 23 | 2,489 | -7,323 | 7,216 | 1,203 |
| 30 Sep 23 | 3,419 | -6,852 | 6,809 | 1,762 |
| 30 Jun 23 | 4,016 | -6,252 | 6,614 | 2,065 |
| 31 Mar 23 | 4,336 | -6,608 | 7,074 | 2,422 |
| 31 Dec 22 | 3,415 | -9,012 | 7,705 | 2,938 |
| 30 Sep 22 | 4,674 | -8,014 | 8,308 | 2,927 |
| 30 Jun 22 | 4,053 | -8,542 | 8,379 | 2,745 |
| 31 Mar 22 | 3,696 | -8,219 | 7,790 | 2,650 |
| 31 Dec 21 | 3,786 | -7,574 | 7,375 | 2,544 |
| 30 Sep 21 | 4,625 | -7,321 | 7,864 | 2,438 |
| 30 Jun 21 | 4,555 | -7,658 | 8,110 | 2,597 |
| 31 Mar 21 | 4,539 | -7,963 | 8,590 | 2,579 |
| 31 Dec 20 | 4,490 | -7,637 | 8,496 | 2,466 |
| 30 Sep 20 | 558 | -10,675 | 8,107 | 2,325 |
| 30 Jun 20 | 517 | -10,679 | 8,118 | 2,345 |
| 31 Mar 20 | 341 | -11,275 | 8,438 | 2,522 |
| 31 Dec 19 | 230 | -10,609 | 7,634 | 2,510 |
| 30 Sep 19 | 471 | -9,816 | 6,281 | 2,486 |
| 31 Dec 18 | 363 | -6,196 | 2,428 | 2,162 |
Quality Earnings: A322510 is currently unprofitable.
Growing Profit Margin: A322510 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A322510 is unprofitable, but has reduced losses over the past 5 years at a rate of 4.6% per year.
Accelerating Growth: Unable to compare A322510's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A322510 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (11.1%).
Return on Equity
High ROE: A322510 has a negative Return on Equity (-186.53%), as it is currently unprofitable.